[(1S,3R,7R,10S,12R,13R,14S,15S,17R,18R,19R,21S)-1,15-dihydroxy-9,9,14,18-tetramethyl-19-(4-methyl-5-oxooxolan-2-yl)-5-oxo-4,8,20-trioxahexacyclo[11.10.0.03,7.03,10.014,21.017,21]tricosan-12-yl] acetate

C31H44O10 — CID 102395582

IUPAC[(1S,3R,7R,10S,12R,13R,14S,15S,17R,18R,19R,21S)-1,15-dihydroxy-9,9,14,18-tetramethyl-19-(4-methyl-5-oxooxolan-2-yl)-5-oxo-4,8,20-trioxahexacyclo[11.10.0.03,7.03,10.014,21.017,21]tricosan-12-yl] acetate
SMILESCC(=O)O[C@@H]1C[C@H]2C(C)(C)O[C@@H]3CC(=O)O[C@@]32C[C@@]2(O)CC[C@]34O[C@@H](C5CC(C)C(=O)O5)[C@H](C)[C@H]3C[C@H](O)[C@]4(C)[C@H]12
InChIInChI=1S/C31H44O10/c1-14-9-18(38-26(14)35)24-15(2)17-10-21(33)28(6)25-19(37-16(3)32)11-20-27(4,5)39-22-12-23(34)40-30(20,22)13-29(25,36)7-8-31(17,28)41-24/h14-15,17-22,24-25,33,36H,7-13H2,1-6H3/t14?,15-,17-,18?,19-,20+,21+,22-,24-,25+,28-,29+,30-,31+/m1/s1
InChIKeyTYIFGMPLIUCLBI-MNKDMAAGSA-N
MW576.68 g/mol
LogP2.44
Rot. Bonds2

About [(1S,3R,7R,10S,12R,13R,14S,15S,17R,18R,19R,21S)-1,15-dihydroxy-9,9,14,18-tetramethyl-19-(4-methyl-5-oxooxolan-2-yl)-5-oxo-4,8,20-trioxahexacyclo[11.10.0.03,7.03,10.014,21.017,21]tricosan-12-yl] acetate

[(1S,3R,7R,10S,12R,13R,14S,15S,17R,18R,19R,21S)-1,15-dihydroxy-9,9,14,18-tetramethyl-19-(4-methyl-5-oxooxolan-2-yl)-5-oxo-4,8,20-trioxahexacyclo[11.10.0.03,7.03,10.014,21.017,21]tricosan-12-yl] acetate (PubChem CID 102395582) has the molecular formula C31H44O10 and a molecular weight of 576.68 g/mol. Its IUPAC name is [(1S,3R,7R,10S,12R,13R,14S,15S,17R,18R,19R,21S)-1,15-dihydroxy-9,9,14,18-tetramethyl-19-(4-methyl-5-oxooxolan-2-yl)-5-oxo-4,8,20-trioxahexacyclo[11.10.0.03,7.03,10.014,21.017,21]tricosan-12-yl] acetate.

Molecular Properties

Compound Name[(1S,3R,7R,10S,12R,13R,14S,15S,17R,18R,19R,21S)-1,15-dihydroxy-9,9,14,18-tetramethyl-19-(4-methyl-5-oxooxolan-2-yl)-5-oxo-4,8,20-trioxahexacyclo[11.10.0.03,7.03,10.014,21.017,21]tricosan-12-yl] acetate
PubChem CID102395582
Molecular FormulaC31H44O10
Molecular Weight576.68 g/mol
Exact Mass576.29
IUPAC Name[(1S,3R,7R,10S,12R,13R,14S,15S,17R,18R,19R,21S)-1,15-dihydroxy-9,9,14,18-tetramethyl-19-(4-methyl-5-oxooxolan-2-yl)-5-oxo-4,8,20-trioxahexacyclo[11.10.0.03,7.03,10.014,21.017,21]tricosan-12-yl] acetate
SMILESCC(=O)O[C@@H]1C[C@H]2C(C)(C)O[C@@H]3CC(=O)O[C@@]32C[C@@]2(O)CC[C@]34O[C@@H](C5CC(C)C(=O)O5)[C@H](C)[C@H]3C[C@H](O)[C@]4(C)[C@H]12
InChIInChI=1S/C31H44O10/c1-14-9-18(38-26(14)35)24-15(2)17-10-21(33)28(6)25-19(37-16(3)32)11-20-27(4,5)39-22-12-23(34)40-30(20,22)13-29(25,36)7-8-31(17,28)41-24/h14-15,17-22,24-25,33,36H,7-13H2,1-6H3/t14?,15-,17-,18?,19-,20+,21+,22-,24-,25+,28-,29+,30-,31+/m1/s1
InChIKeyTYIFGMPLIUCLBI-MNKDMAAGSA-N
XLogP2.44
TPSA137.82 Ų
H-Bond Donors2
H-Bond Acceptors10
Rotatable Bonds2
Heavy Atoms41
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500576.68
LogP ≤ 52.44
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}

Analyze [(1S,3R,7R,10S,12R,13R,14S,15S,17R,18R,19R,21S)-1,15-dihydroxy-9,9,14,18-tetramethyl-19-(4-methyl-5-oxooxolan-2-yl)-5-oxo-4,8,20-trioxahexacyclo[11.10.0.03,7.03,10.014,21.017,21]tricosan-12-yl] acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(1S,3R,7R,10S,12R,13R,14S,15S,17R,18R,19R,21S)-1,15-dihydroxy-9,9,14,18-tetramethyl-19-(4-methyl-5-oxooxolan-2-yl)-5-oxo-4,8,20-trioxahexacyclo[11.10.0.03,7.03,10.014,21.017,21]tricosan-12-yl] acetate?
The IUPAC name of [(1S,3R,7R,10S,12R,13R,14S,15S,17R,18R,19R,21S)-1,15-dihydroxy-9,9,14,18-tetramethyl-19-(4-methyl-5-oxooxolan-2-yl)-5-oxo-4,8,20-trioxahexacyclo[11.10.0.03,7.03,10.014,21.017,21]tricosan-12-yl] acetate (CID 102395582) is [(1S,3R,7R,10S,12R,13R,14S,15S,17R,18R,19R,21S)-1,15-dihydroxy-9,9,14,18-tetramethyl-19-(4-methyl-5-oxooxolan-2-yl)-5-oxo-4,8,20-trioxahexacyclo[11.10.0.03,7.03,10.014,21.017,21]tricosan-12-yl] acetate.
What is the SMILES notation for [(1S,3R,7R,10S,12R,13R,14S,15S,17R,18R,19R,21S)-1,15-dihydroxy-9,9,14,18-tetramethyl-19-(4-methyl-5-oxooxolan-2-yl)-5-oxo-4,8,20-trioxahexacyclo[11.10.0.03,7.03,10.014,21.017,21]tricosan-12-yl] acetate?
The canonical SMILES for [(1S,3R,7R,10S,12R,13R,14S,15S,17R,18R,19R,21S)-1,15-dihydroxy-9,9,14,18-tetramethyl-19-(4-methyl-5-oxooxolan-2-yl)-5-oxo-4,8,20-trioxahexacyclo[11.10.0.03,7.03,10.014,21.017,21]tricosan-12-yl] acetate is CC(=O)O[C@@H]1C[C@H]2C(C)(C)O[C@@H]3CC(=O)O[C@@]32C[C@@]2(O)CC[C@]34O[C@@H](C5CC(C)C(=O)O5)[C@H](C)[C@H]3C[C@H](O)[C@]4(C)[C@H]12.
What is the InChIKey of [(1S,3R,7R,10S,12R,13R,14S,15S,17R,18R,19R,21S)-1,15-dihydroxy-9,9,14,18-tetramethyl-19-(4-methyl-5-oxooxolan-2-yl)-5-oxo-4,8,20-trioxahexacyclo[11.10.0.03,7.03,10.014,21.017,21]tricosan-12-yl] acetate?
The InChIKey is TYIFGMPLIUCLBI-MNKDMAAGSA-N. The full InChI is InChI=1S/C31H44O10/c1-14-9-18(38-26(14)35)24-15(2)17-10-21(33)28(6)25-19(37-16(3)32)11-20-27(4,5)39-22-12-23(34)40-30(20,22)13-29(25,36)7-8-31(17,28)41-24/h14-15,17-22,24-25,33,36H,7-13H2,1-6H3/t14?,15-,17-,18?,19-,20+,21+,22-,24-,25+,28-,29+,30-,31+/m1/s1.
What are the key properties of [(1S,3R,7R,10S,12R,13R,14S,15S,17R,18R,19R,21S)-1,15-dihydroxy-9,9,14,18-tetramethyl-19-(4-methyl-5-oxooxolan-2-yl)-5-oxo-4,8,20-trioxahexacyclo[11.10.0.03,7.03,10.014,21.017,21]tricosan-12-yl] acetate?
[(1S,3R,7R,10S,12R,13R,14S,15S,17R,18R,19R,21S)-1,15-dihydroxy-9,9,14,18-tetramethyl-19-(4-methyl-5-oxooxolan-2-yl)-5-oxo-4,8,20-trioxahexacyclo[11.10.0.03,7.03,10.014,21.017,21]tricosan-12-yl] acetate has a molecular weight of 576.68 g/mol, XLogP of 2.44, 2 rotatable bonds, 2 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for [(1S,3R,7R,10S,12R,13R,14S,15S,17R,18R,19R,21S)-1,15-dihydroxy-9,9,14,18-tetramethyl-19-(4-methyl-5-oxooxolan-2-yl)-5-oxo-4,8,20-trioxahexacyclo[11.10.0.03,7.03,10.014,21.017,21]tricosan-12-yl] acetate is sourced from PubChem (CID 102395582), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).